Rockwood / Kingston Psychiatric Hospital / Providence Continuing Care Centre Collection
Physician's sample packet of six green Parstelin tablets in clear plastic blister pack glued at the bottom to a 29.0 cm long folded paper information sheet; once the paper is folded five times around the tablets a package is created; printing on both sides; section where tablets are attached is per…
Physician's sample packet of six green Parstelin tablets in clear plastic blister pack glued at the bottom to a 29.0 cm long folded paper information sheet; once the paper is folded five times around the tablets a package is created; printing on both sides; section where tablets are attached is perforated to tear off as a prescription; tablets have initials SKF on one side.
Front of packet: "Parstelin* // (combination of Parnate* and Stelazine*) // dual-action therapy to relieve // CO-EXISTENT DEPRESSION AND ANXIETY // Smith Kline & French . Montreal 9 // * Reg. Can. T.M. Off. // 6 Tablets Physician's Sample // 'Parstelin' is a combination of two outstandingly // useful psychotherapeutic agents deevloped by SK&F // research - 'Parnate' and 'Stelazine'. // FORMULA // INDICASTIONS // DOSAGE: Uusual dosage is one tablet twice daily - morn- // ing and afternoon.The first signs of improvement are // frequently seen within one to three days and usually // witin a week. If an increase in dosage is required, one // tablet shoudl be added in the morning dose after the first // week of therapy. // Pat. No. 616,537 (1961) Pat. No. 612,204 (1961) // PRECAUTIONS // CONTRAINDICATION // HOW SUPPLIED // CG : 336 // LOT D 1566"
Storage Room 0010
open flat = Length 29.0 cm x Width 8.4 cm x Depth 0.3 cm
Shows minor wear on front and back; tablets are complete and undamaged; all printing is fully legible
Tranylcypromine / trifluoperazine (brand names Parstelin, Parmodalin, Jatrosom N, Stelapar) is a combination formulation of the monoamine oxidase inhibitor antidepressant drug tranylcypromine and the typical antipsychotic drug trifluoperazine that has been used in the treatment of major depressive disorder. It contains 10 mg tranylcypromine and 1 mg trifluoperazine.The drug has been in clinical use since at least 1961.It is still available in Italy with the name of Parmodalin.
Parstelin A brand name for a mixture of TRANYLCYPROMINE and TRIFLUOPERAZINE. Product development discontinued.
On exhibit at Musée de la civilisation de Québec 13 March 2017 - 30 March 2018